MIMS Diabetes Clinic

Latest news and quick-reference resources collated by the MIMS editors to support primary care prescribing for type I and type II diabetes mellitus. 

Latest news

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

The SGLT2 inhibitor dapagliflozin (Forxiga) can now...

Compare COPD inhalers and insulin pens with new MIMS tables

Compare COPD inhalers and insulin pens with new MIMS tables

Quick-reference comparison charts for COPD combination...

NICE approves new diabetes treatment for NHS prescribing

NICE approves new diabetes treatment for NHS prescribing

Ertugliflozin (Steglatro), the newest sodium glucose...

SGLT2 inhibitors: MHRA warns of Fournier's gangrene risk

SGLT2 inhibitors: MHRA warns of Fournier's gangrene risk

Cases of necrotising fasciitis of the genitalia or...

Launch of new SGLT2 inhibitor increases choice in diabetes prescribing

Launch of new SGLT2 inhibitor increases choice in diabetes prescribing

Ertugliflozin (Steglatro) is a sodium glucose co-transporter...

At-a-glance product comparison charts.


Summaries of key national guidance.




From our sister sites

Articles from

Calculators

Promo Image

Proteinuria

Urine albumin: creatinine ratio (ACR), protein: creatinine ratio (PCR), and degree of renal impairment.

Promo Image

HbA 1c units

Enter glycated haemoglobin
( HbA 1c ) value in % to convert to mmol/mol, and vice versa.

This site is intended for healthcare professionals.